On October 5, 2026, JPMorgan Chase & Co. disposed of a security interest in 968,505 H shares of HENGRUI PHARMA via an off-exchange cash transaction at an average price of HKD 48.2915 per share, involving about HKD 46.77 million. On the same day, the institution reduced its short position in HENGRUI PHARMA by returning borrowed shares under a securities lending agreement.
Prior to the disposal, JPMorgan Chase & Co.'s long position in HENGRUI PHARMA was 26.48 million shares, representing 10.25%; following the disposal, the holding changed to 25.51 million shares, with the long position ratio falling to 9.87%. For the short position, prior to the reduction, the short position was 11.98 million shares, representing 4.64%; following the return of borrowed shares, the short position decreased to 8.61 million shares, with the short position ratio falling to 3.33%.